Search
Vyne Therapeutics Inc
VYNEAdd to Watchlist
0.681USD
+0.030+4.66%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
22.71MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Royalty revenues
570.00K
0.00%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Royalty revenues
570.00K
0.00%